Multimodal Prehabilitation Program for Women Undergoing Gynecologic Oncology Surgery

NCT ID: NCT07188662

Last Updated: 2025-09-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

140 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-23

Study Completion Date

2025-07-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to evaluate the role of multimodal Prehabilitation program on improve surgical outcomes after gynecological oncology surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Multimodal prehabilitation program focused on improving woman physical and psychological wellbeing before gynecological oncology surgery. Multimodal prehabilitation refers to a combination of preoperative interventions targeting physical, nutritional, psychological, and medical optimization. This program included various element such preoperative physical exercise, nutritional support, psychological counselling, social support and education about surgical processes. Multimodal Prehabilitation programs play an important role in improving surgical outcomes after gynecological oncology surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gynecologic Oncology Patient

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Conventional group

Conventional group (woman received hospital care at previous year as a retrospective sample to prevent risk of bias) equal 70 woman

Group Type NO_INTERVENTION

No interventions assigned to this group

Prehabilitation group

Prehabilitation group (woman who will receive prehabilitation care combine with ERAS post-operative care as a prospective sample) equal 70 woman

Group Type EXPERIMENTAL

group (B) Prehabilitation care combine with ERAS post-operative care

Intervention Type PROCEDURE

intervention will includes receiving prehabilitation care combine with ERAS post-operative care.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

group (B) Prehabilitation care combine with ERAS post-operative care

intervention will includes receiving prehabilitation care combine with ERAS post-operative care.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Newly diagnosed woman with gynecologic cancer by imaging \&histopathology
* Accept participation in the study.

Exclusion Criteria

* Patient with advanced and metastatic stage
* Patient who received neoadjuvant chemotherapy
* Patient who have psychological disorder such as suicidal attempt
* Patient who have cerebral stroke, hemiplegia or paralyses
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Aya M. Abdelhafez

lecturer of maternity, gynecological and obstetric nursing

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Aziza M Mohammed, Head nurse

Role: STUDY_CHAIR

Woman's Health Hospital, Assiut University, Egypt

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Woman's Health Hospital

Asyut, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MMPPGOS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.